HPV is a skin disease that to establish infection must infect the basal layer. It enters through minor trauma and can infect cells in the cervix, vagina, anus, etc., but won't necessarily infect all cells in all these places. For that reason, you can spread the infection from one spot to another via yourself or your infected partner.
For example, if you don't already have an infection in your anus, having anal sex with an infected partner would increase your odds of spreading HPV to that spot (although it can also migrate there from HPV that's active in your vulva or vagina). Would you consider this new anal HPV infection "reinfection"? I don't think it's exactly reinfection, I think it's just spreading the infection to a new place.
Here is a partner transmission study posted on the CDC website that describes how HPV is spread from partner to partner at multiple sites. There were a lot of instances of the man spreading it himself from penis to scrotum to hand to penis, etc. Bottom line, if you have an active HPV infection, don't scratch!
http://www.cdc.gov/eid/content/14/6/888.htm
I read another study that said that women who use tampons have much less chance of clearing HPV than women who don't. The researchers speculated that the tampons spread the HPV in the vagina. I also wonder whether the act of sex itself could cause the HPV to better establish itself while the infection is active -- just because of the trauma and rubbing.
As long as we haven't developed immunity to the virus, we're susceptible to getting HPV in new places. And, each spot where HPV establishes itself in the basal layer is a potential spot for dysplasia to develop in the future, so it seems to me there would be some value in trying to limit the spread of the infection while it's active in your body (if at all possible).
Now, maybe there is so much viral load during an active infection that it's not possible to limit the extent of the initial infection and maybe a woman has so much viral load that her partner's active infection doesn't really change the course of her own infection.
But, there are at least two research papers that indicate that limiting exposure to a partner's active infection might also help a person clear their own infection. There are the studies by Bleeker that indicate that using condoms can help speed clearance of lesions if couples share the same virus type. His theory is that limiting exposure to a partner's infection limits viral load and helps people clear their own infections.
http://www.ncbi.nlm.nih.gov/pubmed/14566832
http://www.ncbi.nlm.nih.gov/pubmed/14566831?ordinalpos=1&itool=EntrezSystem 2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_Discovery _RA&linkpos=1&log$=relatedarticles&logdbfrom=pubmed
There is also the attached study on genital warts that concludes that continued sex between infected couples hampered effectiveness of treatment. This study suggested couples should stop having sex until the warts of both partners were fully eradicated.
http://dermatology.cdlib.org/134/original/cryo/rasi.html
Joel Palefsky, in his book on HPV and Abnormal Pap Smears also suggests that couples use condoms until any active HPV lesions in both partners have been cleared for three months because "it's common sense." He's an infectious disease expert and does research studies on HPV.
Once we've cleared or suppressed the virus by developing immunity, we don't really know how long this natural immunity lasts and whether it would be protective against a new exposure of the same strain from a new partner or the same partner in the future.
About 1/2 of people never develop detectable antibodies, so antibodies from natural infection aren't nearly the level of antibodies from the Gardasil vaccine. The latest research I read suggests that antibodies don't prevent future infection of the same virus type, but an earlier study suggests that they do. It's hard for researchers to tell what's really going on, since they can't distinguish a new infection from a reactivation of an existing infection.
Also, researchers say that it's possible that immunity is not always humoral (meaning it does not always happen at a system level via antibodies), but is cell-mediated, meaning immunity occurs locally in the cells. Still, researchers don't really know if natural immunity is protective against future infections of the same strain or for how long. Without immunity, there's nothing to prevent additional infection in new places from the same strain of HPV.
We do know that people can get multiple variants of the same strain. For example, when we look at biopsies of dysplasia, we can find two different variants of HPV16 in the same tissue sample indicating that infection with one HPV16 variant didn't prevent a second HPV16 infection with a different variant. So, just because you have HPV16 from one partner, doesn't mean you couldn't get another HPV16 variant from another partner.
I don't know whether it's realistic to worry about a second HPV16 infection, because maybe the odds are low of this happening. I've also wondered whether Gardasil would prevent this second infection, even though it won't clear an existing HPV infection from the basal layer.
During a LEEP or cone procedure, the dysplasia is removed along with the HPV infection that's in the basal layer at the point of the excision. When dysplasia appears to "recur" on the cervix, I've read two research papers that speculate this could occur because of:
1. Not all the HPV was removed from the cervix
2. HPV migrated from vagina or vulva up to the cervix or
3. There was additional HPV infection from an infected partner.
I personally think ongoing sex during an active HPV infection with lesions is a bad idea. I also think, though, that reactivation (virus in some cells going from dormant to active) is probably more likely due to hormonal changes or stress rather than sex with the partner (unless the partner's virus suddenly reactivated at a time when natural immunity in the woman had waned, making her susceptible again). Also, I haven't seen studies on how often "reactivation" occurs and whether this is common or rare. Again, that's because researchers can't really tell when an infection is new versus a recurrence, and they're working on better diagnostics so that they can make that distinction.
Sorry this is so long! I didn't know what people would be interested in versus not. Also, with research, nothing is very definitive, so I think it's really valid to look at all the data and form your own conclusions.





Add to the discussion